未登录Difficult-to-treat resistance (DTR), treatment, and outcomes of carbapenem-resistant Enterobacterales infections in the setting of IMP-type carbapenemase predominance in Japan难治性耐药(DTR)、治疗及结果:日本IMP型碳青霉烯酶占主导的碳青霉烯耐药肠杆菌科细菌感染
Ohyama, Koji; Uemura, Kohei; Matsumura, Yasufumi; Hase, Ryota; Kato, Hideaki; Matono, Takashi; Itoh, Naoya; Hashimoto, Takehiro; Yamamoto, Go; Mawatari, Momoko; Tsutsumi, Takeya; Suzuki, Tetsuya; Suzuki, Masahiro; Hosoda, Takuya; Sakurai, Aki; Asai, Yusuke; Tsuzuki, Shinya; Hayakawa, Kayoko; van Duin, David; Ohmagari, Norio; Doi, Yohei; Saito, Sho
分享
收藏
分享
收藏
分享
收藏In vitro activity of cefiderocol against carbapenem-resistant Gram-negative pathogens in Japan日本环境中cefiderocol对耐碳青霉烯革兰氏阴性病原体的体外活性
Matsui, Kenjiro; Sakurai, Aki; Matsumura, Yasufumi; Hosoda, Takuya; Suzuki, Masahiro; Saito, Sho; Hase, Ryota; Kato, Hideaki; Hashimoto, Takehiro; Matono, Takashi; Itoh, Naoya; Mawatari, Momoko; Uemura, Kohei; Hayakawa, Kayoko; Ito, Hiroyasu; Doi, Yohei
分享
收藏
分享
收藏
分享
收藏
分享
收藏Features of Carbapenem-resistant Gram-negative Bacterial Infections in Japan Based on the Setting of Onset基于发病场所的日本碳青霉烯耐药革兰氏阴性菌感染特征
Kawamoto, Yuya; Asai, Yusuke; Sakurai, Aki; Matsumura, Yasufumi; Hase, Ryota; Kato, Hideaki; Matono, Takashi; Itoh, Naoya; Hashimoto, Takehiro; Yamamoto, Go; Mawatari, Momoko; Tsutsumi, Takeya; Suzuki, Tetsuya; Tsuzuki, Shinya; Ohyama, Koji; Suzuki, Masahiro; Hayakawa, Kayoko; Uemura, Kohei; van Duin, David; Ohmagari, Norio; Doi, Yohei; Saito, Sho
分享
收藏
分享
收藏
分享
收藏
分享
收藏Molecular epidemiology and patient outcome of carbapenem-resistant Enterobacterales, Pseudomonas aeruginosa and Acinetobacter baumannii in Japan: a multicenter study from MultiDrug-Resistant organisms clinical research network
Saito, Sho; Sakurai, Aki; Matsumura, Yasufumi; Uemura, Kohei; Hase, Ryota; Kato, Hideaki; Itoh, Naoya; Hashimoto, Takehiro; Matono, Takashi; Yu, Jiefu; Hayakawa, Kayoko; Suzuki, Masahiro; Izumi, Shoki; Suzuki, Tetsuya; Kurokawa, Mari; Shinohara, Koh; Mori, Keiichiro; Endo, Yasunobu; Mito, Haruki; Sano, Kayoko; Matsunaga, Tomo; Akazawa, Nana; Hiramatsu, Kazufumi; Asai, Yusuke; Tsuzuki, Shinya; van Duin, David; Ohmagari, Norio; Doi, Yohei
分享
收藏Prevalence of erectile dysfunction as long-COVID symptom in hospitalized Japanese patients
Kato, Hideaki; Ichihara, Nao; Saito, Hiroki; Fujitani, Shigeki; Ota, Kohei; Takahashi, Yuji; Harada, Toshiyuki; Hattori, Takeshi; Komeya, Mitsuru; Hosozawa, Mariko; Muto, Yoko; Hori, Miyuki; Iba, Arisa; Iso, Hiroyasu
分享
收藏Impact of Nutritional Therapy during Intensive Care Unit Admission on Post-Intensive Care Syndrome in Patients with COVID-19
Suganuma, Shinya; Nakamura, Kensuke; Kato, Hideaki; Hemmi, Muneaki; Kawabata, Keiichiro; Hosozawa, Mariko; Muto, Yoko; Hori, Miyuki; Iba, Arisa; Asahi, Tomohiro; Kawauchi, Akira; Fujitani, Shigeki; Hatakeyama, Junji; Oshima, Taku; Ota, Kohei; Kamijo, Hiroshi; Iso, Hiroyasu
分享
收藏
分享
收藏Clinical characteristics and genome epidemiology of Stenotrophomonas maltophilia in Japan
Hase, Ryota; Sakurai, Aki; Suzuki, Masahiro; Itoh, Naoya; Hayakawa, Kayoko; Uemura, Kohei; Matsumura, Yasufumi; Kato, Hideaki; Ishihara, Takuma; van Duin, David; Ohmagari, Norio; Doi, Yohei; Saito, Sho
分享
收藏Characterization of a SARS-CoV-2 EG.5.1 clinical isolate in vitro and in vivo
Uraki, Ryuta; Kiso, Maki; Iwatsuki-Horimoto, Kiyoko; Yamayoshi, Seiya; Ito, Mutsumi; Chiba, Shiho; Sakai-Tagawa, Yuko; Imai, Masaki; Kashima, Yukie; Koga, Michiko; Fuwa, Noriko; Okumura, Nobumasa; Hojo, Masayuki; Iwamoto, Noriko; Kato, Hideaki; Nakajima, Hideaki; Ohmagari, Norio; Yotsuyanagi, Hiroshi; Suzuki, Yutaka; Kawaoka, Yoshihiro
分享
收藏
分享
收藏Effectiveness of cefmetazole versus meropenem for invasive urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli
Hayakawa, Kayoko; Matsumura, Yasufumi; Uemura, Kohei; Tsuzuki, Shinya; Sakurai, Aki; Tanizaki, Ryutaro; Shinohara, Koh; Hashimoto, Takehiro; Hase, Ryota; Matono, Takashi; Kato, Hideaki; Mawatari, Momoko; Hara, Hiroshi; Hamada, Yukihiro; Saito, Sho; Ohmagari, Norio; Doi, Yohei
分享
收藏Effectiveness of BA.1-and BA.4/BA. 5-Containing Bivalent COVID-19 mRNA Vaccines Against Symptomatic SARS-CoV-2 Infection During the BA.5-Dominant Period in JapanBA.1-和BA.4/BA的效力。含5种二价新型冠状病毒肺炎mRNA疫苗,在日本的BA.5显性时期对抗有症状的SARS-CoV-2感染
Arashiro, Takeshi; Arima, Yuzo; Kuramochi, Jin; Muraoka, Hirokazu; Sato, Akihiro; Chubachi, Kumi; Yanai, Atsushi; Arioka, Hiroko; Uehara, Yuki; Ihara, Genei; Kato, Yasuyuki; Yanagisawa, Naoki; Ueda, Akihiro; Kato, Hideaki; Oka, Hideaki; Nishida, Yusuke; Nidaira, Yuki; Asami, Takahiro; Jinta, Torahiko; Nakamura, Akira; Oba, Kunihiro; Taniyama, Daisuke; Yamamoto, Kei; Tanaka, Katsushi; Ueshima, Kankuro; Fuwa, Tetsuji; Stucky, Ashley; Suzuki, Tadaki; Smith, Chris; Hibberd, Martin; Ariyoshi, Koya; Suzuki, Motoi
分享
收藏